LuxuryCare Supports Groundbreaking Norovirus mRNA Vaccine Trial to Safeguard Residents and Staff

by | Dec 19, 2024 | News

LuxuryCare, a leading care provider in Bournemouth and Poole, proudly celebrates a significant advancement in healthcare – the UK’s first-ever Norovirus mRNA vaccine trial, launched by the National Institute for Health Research (NIHR). This pioneering initiative promises to transform the way care homes manage the seasonal threat of Norovirus, a highly contagious virus often referred to as the “winter vomiting bug.”

A New Era in Norovirus Prevention

Norovirus outbreaks are a recurring challenge for care homes, posing serious health risks to elderly residents and impacting the well-being of dedicated care staff. The development of an mRNA vaccine represents a breakthrough in safeguarding vulnerable populations. By mitigating the risks associated with Norovirus, care homes like those operated by LuxuryCare can focus on delivering consistent, high-quality care without the disruptions caused by outbreaks.

Jacqueline Macon, Home Manager at Eagles Mount Care Home, shared her enthusiasm for the trial, stating:

“Norovirus outbreaks can disrupt not only the health of our residents but also the continuity of care and the wellbeing of our staff. We are delighted to support this trial and welcome opportunities to share our insights on Norovirus management within care environments. Our team is keen to contribute to this groundbreaking research and looks forward to seeing the positive impact on our residents and the wider care community.”

A Commitment to Innovation and Wellbeing

LuxuryCare’s involvement in this innovative research underscores their commitment to advancing healthcare measures that prioritise resident safety and wellbeing. By supporting the Norovirus mRNA vaccine trial, LuxuryCare is taking proactive steps to address seasonal health challenges and lead by example in the care sector.

Media Invitation

LuxuryCare extends a warm invitation to media representatives to visit Eagles Mount Care Home, where proactive measures against Norovirus are already in place. This is an opportunity to witness firsthand the dedication of staff and residents to enhancing health outcomes, as well as the vital role care homes play in supporting cutting-edge research.

♡
KANESBURY CARE
AUTHOR Bio

Kanesbury Care

Kanesbury Care is an independent, family-run group of care homes committed to providing exceptional, compassionate care in environments that truly feel like home. With more than 25 years of experience, Kanesbury Care has grown from a single home into a trusted group of six, while remaining guided by the family values that shaped its beginnings.

The organisation places genuine relationships, dignity, respect, and personalised support at the heart of everyday care. Its experienced teams take the time to understand each resident, providing continuity, familiarity, and thoughtful care tailored to individual needs.

Kanesbury Care’s commitment to excellence has been recognised through multiple ‘Outstanding’ CQC ratings across its homes. Every decision is guided by a simple principle:

“

Would we be happy if it were our mum?

The values behind everything we do.

Today, Kanesbury Care continues to grow with purpose, creating welcoming homes where residents feel safe, valued, supported, and truly at home every day and every step.